Log in

Relevant bibliographies by topics / Therapeutic algorithms / Books

To see the other types of publications on this topic, follow the link: Therapeutic algorithms.

Books on the topic 'Therapeutic algorithms'

Author: Grafiati

Published: 7 June 2025

Last updated: 16 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 29 books for your research on the topic 'Therapeutic algorithms.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Millikan, Keith W., Jonathan A. Myers, and Theodore J. Saclarides. Common surgical diseases: An algorithmic approach to problem solving. Springer, 2015.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Amara, Lynn. Acute therapeutics for the homeopathic practitioner: A compendium of algorithm charts and flow charts. Amara, 1996.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Vasquez, Alex. Integrative rheumatology ; concepts, algorithms, and therapeutics: Creating wellness while effectively managing acute and chronic musculoskeletal disorders. Natural Health Consulting Corp., 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

W, Millikan Keith, Saclarides Theodore J. 1956-, and SpringerLink (Online service), eds. Common Surgical Diseases: An Algorithmic Approach to Problem Solving. Springer Science+Business Media, LLC, 2008.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Berihanova, Rumisa, and Inessa Minenko. Complex non-drug correction of menopausal disorders in patients with metabolic syndrome. INFRA-M Academic Publishing LLC., 2021. http://dx.doi.org/10.12737/1599004.

Full text

Abstract:

The monograph is devoted to the complex non-drug correction of menopausal disorders in patients with metabolic syndrome in the period of menopausal transition. Modern ideas about menopausal and metabolic syndromes are presented, a review of modern approaches to their treatment is carried out.  A complex personalized system of non-drug correction of functional disorders in patients with metabolic syndrome and menopausal syndrome of mild and moderate severity in the period of menopausal transition is presented, including preformed therapeutic factors (vibrotherapy, chromotherapy, aeroionotherapy, musicotherapy (melotherapy), aromatherapy), physical therapy with pelvic floor muscle training, drinking balneotherapy, vitamins and minerals against the background of lifestyle modification. The algorithm of dynamic clinical and laboratory examination of women with menopausal disorders of mild and moderate severity and metabolic syndrome in the period of menopausal transition has been developed, including a general clinical examination, assessment of alimentary, thyroid, psycho-emotional, gynecological, urological statuses, the state of the intestinal microbiota, the function of the hypothalamic-pituitary complex, biochemical blood profile, hemostasis, levels of markers of inflammation, assessment of the state of the musculoskeletal system, sexual function, allowing to get an idea of the state of mental and physical health of patients, evaluate the effectiveness of the complex of measures, optimize therapeutic tactics. It is addressed to a wide range of readers interested in women's health. It can be useful for students, postgraduates, teachers of medical universities, obstetricians, gynecologists, endocrinologists, cardiologists, specialists of restorative medicine.

APA, Harvard, Vancouver, ISO, and other styles

6

Vasquez, Alex. Integrative orthopedics: Integrative, nutritional, botanical, and manipulative therapeutics with concepts, perspectives, algorithms, and protocols for the in-office diagnosis and management of the most common neuromusculoskeletal problems. 2nd ed. Integrative and Biological Medicine Research and Consulting, LLC, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Quantitative neuroscience: Models, algorithms, diagnostics, and therapeutic applications. Kluwer Academic, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Pardalos, P. M. Quantitative Neuroscience: Models, Algorithms, Diagnostics, and Therapeutic Applications. Springer London, Limited, 2013.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Pardalos, P. M. Quantitative Neuroscience: Models, Algorithms, Diagnostics, and Therapeutic Applications. Springer, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Pardalos, P. M. Quantitative Neuroscience: Models, Algorithms, Diagnostics, and Therapeutic Applications. Springer, 2013.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

11

Quantitative Neuroscience: Models, Algorithms, Diagnostics, and Therapeutic Applications (Biocomputing). Springer, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

12

Diagnostic and Therapeutic Algorithms in Internal Medicine for Dogs and Cats. Edra Publishing US LLC, 2022.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

13

Fracassi, Federico. Diagnostic-therapeutic algorithms in internal medicine for dogs and cats 1st edition. Edra Publishing US LLC, 2022.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

14

Diagnostic-Therapeutic Algorithms in Internal Medicine for Dogs and Cats 1st Edition. Edra Publishing US LLC, 2024.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

15

Vasquez, Alex. Integrative Rheumatology: Concepts, Algorithms, and Therapeutics. Integrative and Biological Medicine Research and Consulting, LLC, 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

16

Lüscher, Thomas, ed. Manual of Cardiovascular Medicine. Oxford University Press, 2021. http://dx.doi.org/10.1093/med/9780198850311.001.0001.

Full text

Abstract:

Cardiovascular medicine has experienced an unforeseen and impressive development over the last fifty years, particularly recently, as new diagnostic innovative medications have been developed, as well as interventional and surgical procedures to treat patients with cardiac disease. Thus, the number of cardiovascular diagnoses, the number of diagnostic modalities, as well as the number of treatment options has expanded enormously and made cardiovascular medicine one of the biggest specialties in medicine. This cardiovascular manual focuses on diagnostic algorithms and therapeutic recommendations according to European Guidelines. It encompasses all aspects of cardiovascular medicine from hypertension to transplantation; from imaging to intervention; and from pharmacotherapy to surgical procedures.

APA, Harvard, Vancouver, ISO, and other styles

17

Arulkumaran, Sabaratnam, William Ledger, Lynette Denny, and Stergios Doumouchtsis, eds. Oxford Textbook of Obstetrics and Gynaecology. Oxford University Press, 2020. http://dx.doi.org/10.1093/med/9780198766360.001.0001.

Full text

Abstract:

The Oxford Textbook of Obstetrics and Gynaecology is an up-to-date, objective, and readable text that covers the full speciality of obstetrics and gynaecology. This comprehensive and rigorously referenced textbook will be a vital resource in print and online for all practising clinicians. Larger sections on the basics in obstetrics and gynaecology, fetomaternal medicine, management of labour, gynaecological problems, and gynaecological oncology are complemented by specialist sections on areas such as neonatal care and neonatal problems, reproductive medicine, and urogynaecology and pelvic floor disorders, to name a few. The evidence-based presentation of current diagnostic and therapeutic methods is complemented in the text by numerous treatment algorithms, giving the reader the knowledge and tools needed for effective clinical practice.

APA, Harvard, Vancouver, ISO, and other styles

18

Hazell, Philip. The treatment of bipolar disorder in children and adolescents. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780198748625.003.0021.

Full text

Abstract:

The presentation of bipolar disorder in young people can be different from that of adults; therefore, the approach to treatment differs slightly. Treatment is described for early intervention, acute mania, bipolar depression, relapse prevention, and refractory bipolar disorder. A strong therapeutic alliance with the patient and engagement and involvement of the patient’s family is critical to successful intervention. The evidence informing treatment is limited, but there is emerging research focused on the management of acute mania favouring monotherapy with a second-generation antipsychotic (SGA) over a mood stabilizer. Preliminary data favour a combination of an SGA and antidepressant over monotherapy with an SGA for the treatment of bipolar depression. Guidelines endorse electroconvulsive therapy for refractory mania and bipolar depression but there is no clinical trial evidence to support this practice. The development of algorithms to guide the management of all phases of bipolar disorder is a work in progress.

APA, Harvard, Vancouver, ISO, and other styles

19

Goodman, Wayne K., and Mark S. George. Neuromodulation and Psychiatric Disorders. Edited by Dennis S. Charney, Eric J. Nestler, Pamela Sklar, and Joseph D. Buxbaum. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190681425.003.0010.

Full text

Abstract:

An increasing number of approaches permit psychiatrists to directly stimulate the brain. Such therapies are sometimes referred to as neuromodulation, as psychiatrists can either excite or inhibit neuronal firing in the brain. This chapter reviews two such technologies—transcranial magnetic stimulation (TMS) and deep brain stimulation (DBS). Both techniques have FDA approval and are moving into mainstream therapeutic use. Daily prefrontal TMS for 4–6 weeks is FDA approved for treating depression, with minimal side effects. It is now accepted in most treatment algorithms as an approach for patients who have not responded to medications or talking therapy. DBS has virtually replaced ablative neurosurgery for use in medication-refractory movement disorders such as Parkinson’s Disease (PD), where it has the advantages of being reversible (explantable) and adjustable. DBS is now being studied in severe psychiatric conditions, such as intractable obsessive-compulsive disorder (OCD) and treatment resistant depression (TRD).

APA, Harvard, Vancouver, ISO, and other styles

20

Fragoulis, George E., and Iain B. McInnes. Small molecules in the treatment of psoriatic arthritis. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198737582.003.0031.

Full text

Abstract:

Psoriatic arthritis (PsA) is a chronic inflammatory arthritis, occurring in about one third of psoriasis patients, and exhibiting very varied clinical manifestations and comorbidities. Although the clinical outcome of the disease has been significantly improved recently, mainly due to utilization of novel agents targeting the IL-23/-17 axis, unmet needs still exist. Emerging insights into the disease’s pathogenesis led to development of new drugs acting against critical molecular targets and their efficacy in psoriasis and/or PsA has been tested in Phase III clinical trials. Some of these therapeutic regimens have been already approved; some look promising but others have been proven inefficacious. Future studies are expected to determine the place of these compounds within the therapeutic algorithm of PsA. In this chapter we describe the rationale and clinical impact of incorporating small molecules in PsA treatment, as well as specific molecules involved in pathogenesis that may serve as therapeutic targets.

APA, Harvard, Vancouver, ISO, and other styles

21

Greene, Harry L., William P. Johnson, and Dawn Lemcke. Decision Making in Medicine: An Algorithmic Approach. 2nd ed. Mosby, 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

22

Economou, S. G., Theodore J. Saclarides, Keith W. Millikan, and Jonathan A. Myers. Common Surgical Diseases: An Algorithmic Approach to Problem Solving. Springer, 2013.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

23

Vasquez, Alex. Integrative Orthopedics: Concepts, Algorithms, and Therapeutics--The Art of Creating Wellness While Effectively Managing Acute and Chronic Musculoskeletal Disorders. Natural Health Consulting Corporation, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

24

Robb, Jessica F., and Lawrence M. Samkoff. Immunomodulatory Agents for Relapsing-Remitting Multiple Sclerosis. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199341016.003.0025.

Full text

Abstract:

The treatment of multiple sclerosis has become much more complicated with the development of new oral and other disease-modifying therapies (DMT) that have been added to the formulary of older injectables and natalizumab. To date, twelve medications have been approved in the United States for use in cases of relapsing multiple sclerosis. Neurologists managing patients with multiple sclerosis must integrate numerous variables when selecting the appropriate agent for each individual. This chapter presents an overview of the DMTs currently approved by the U.S. Food and Drug Administration for multiple sclerosis and suggests a therapeutic algorithm to aid in choosing among these medications.

APA, Harvard, Vancouver, ISO, and other styles

25

Oberhaus, Daniel. The Silicon Shrink. The MIT Press, 2025. https://doi.org/10.7551/mitpress/14919.001.0001.

Full text

Abstract:

Why the race to apply AI in psychiatry is so dangerous, and how to understand the new tech-driven psychiatric paradigm. AI psychiatrists promise to detect mental disorders with superhuman accuracy, provide affordable therapy for those who can't afford or can't access treatment, and even invent new psychiatric drugs. But the hype obscures an unnerving reality.In The Silicon Shrink, Daniel Oberhaus tells the inside story of how the quest to use AI in psychiatry has created the conditions to turn the world into an asylum. Most of these systems, he writes, have vanishingly little evidence that they improve patient outcomes, but the risks they pose have less to do with technological shortcomings than with the application of deeply flawed psychiatric models of mental disorder at unprecedented scale. Oberhaus became interested in the subject of mental health after tragically losing his sister to suicide. In The Silicon Shrink, he argues that these new, ostensibly therapeutic technologies already pose significant risks to vulnerable people, and they won't stop there. These new breeds of AI systems are creating a psychiatric surveillance economy in which the emotions, behavior, and cognition of everyday people are subtly manipulated by psychologically savvy algorithms that have escaped the clinic. Oberhaus also introduces readers to the concept of “swipe psychology,” which is quickly establishing itself as the dominant mode of diagnosing and treating mental disorders. It is not too late to change course, but to do so means we must reckon with the nature of mental illness, the limits of technology, and what it means to be human.

APA, Harvard, Vancouver, ISO, and other styles

26

Giesser, Barbara S., ed. Primer on Multiple Sclerosis. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199341016.001.0001.

Full text

Abstract:

Primer on Multiple Sclerosis, second edition is designed to be a practical guide to the basic science and clinical manifestations of multiple sclerosis. It is intended primarily for neurologists and other health care professionals who treat persons with this disease. The book starts with a review of the history of multiple sclerosis and the basic genetics, immunology, electrophysiology, and pathophysiology that are central to the disease. It then reviews the common and uncommon clinical signs and symptoms of multiple sclerosis and the management of these conditions. The latest diagnostic strategies are presented. There is extensive coverage of approved and experimental disease-modifying therapies, including algorithms to assist clincians in choosing these therapies. Complementary and alternative therapies that are popular among persons with multiple sclerosis are examined. New additions to this edition include a chapter for nursing health care professionals, and updates on therapeutics. Unique to this book are the chapters on the legal, psychosocial, and vocational issues that often present challenges for person with multiple sclerosis, topics that typically are not covered in standard texts.

APA, Harvard, Vancouver, ISO, and other styles

27

AlJaroudi, Wael. Risk Assessment in Acute Coronary Syndromes. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199392094.003.0013.

Full text

Abstract:

Acute coronary syndromes (ACS) include unstable angina pectoris (UAP), non-ST elevation (NSTEMI), and ST elevation acute myocardial infarction (STEMI). Each year, more than 2 million people are hospitalized with ACS in the United States. The initial treatment has evolved over the last few decades from conservative management to early reperfusion therapy. Medical therapy has also significantly changed with the use of newer more potent antiplatelet agents, beta-blockers, angiotensin converting enzyme inhibitors, statins, and anti-anginal drugs, which have resulted in improvement of patient care and survival. There is no role for stress myocardial perfusion imaging (MPI) in the acute presentation; however, rest MPI may be used to identify the culprit lesion and risk stratify patients if injected during chest pain. In stable patients for ACS, submaximal exercise or vasodilator MPI can be performed as early as 48 hours after the event. Several gated MPI-derived variables such as left ventricular (LV) ejection fraction (EF), LV volumes, infarct size, mechanical dyssynchrony, and residual ischemic burden can risk stratify patients and provide prognostic data incremental to validated clinical risk scores such as GRACE (Global Registry of Acute Coronary Syndrome) and TIMI (Thrombolysis in Myocardial Infarction). Patients with depressed LVEF, remodeled LV, and large perfusion defects are at particularly high- risk for subsequent cardiac death or recurrent myocardial infarction. In such setting, MPI plays a pivotal role in the management of patients and guiding therapeutic decisions. The current chapter will review the clinical and MPI predictors of outcomes in patients presenting with ACS according to updated guidelines and a proposed algorithm integrating the role of MPI in guiding therapeutic decisions and management.

APA, Harvard, Vancouver, ISO, and other styles

28

Jiang, Tao, Michael Q. Zhang, Ying Xu, Pavel Pevzner, and Sorin Istrail. Current Topics in Computational Molecular Biology. MIT Press, 2002.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

29

(Editor), Tao Jiang, Ying Xu (Editor), and Michael Q. Zhang (Editor), eds. Current Topics in Computational Molecular Biology (Computational Molecular Biology). The MIT Press, 2002.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!